Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PROMETEO

Financiado

Cerrado

PRoduction of an innOvative Millifluidic dEvice for TEsting of new prObiotics

Over the last decades, the gut intestinal microflora and other microbial communities present in our body raised a strong interest in the health research domain as it was discovered their possible relation to the pathophysiology of... ver más

31/03/2025

POLIMI

Presupuesto desconocido

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-10-01

ERC-2022-POC2: ERC PROOF OF CONCEPT GRANTS2 Objective:Objectives:

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

POLIMI

Lider

Proyectos interesantes

TALENTS

Medical Technol...

Data Science

2M€ Cerrado

TALENTS

Medical Technol...

Data Science

Cerrado

PID2021-127318OB-I00

Medical Technol...

Data Science

133K€ Cerrado

MicroREvolution

Medical Technol...

Data Science

213K€ Cerrado

CHAARM

Medical Technol...

Data Science

17M€ Cerrado

ONCOTICS

Medical Technol...

Data Science

71K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 17 meses Fecha Inicio: 2023-10-01
Fecha Fin: 2025-03-31

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Over the last decades, the gut intestinal microflora and other microbial communities present in our body raised a strong interest in the health research domain as it was discovered their possible relation to the pathophysiology of major organs and systems. Gut epithelial cells, together with our resident microbiota, are involved in the modulation of the host immune system and represent the first line of adsorption of drugs and nutraceuticals. In parallel to microbiota studies, a great effort has been devoted to assess the role of the “probiotics”, live microorganisms that, administered in adequate amounts, are able to confer a benefit to the host health. Probiotics are currently widely used in the prevention/treatment of many diseases. One critical point that is still an issue in the characterisation of new potential probiotics is the difficulty in mimicking with high reliability the gut microenvironment condition using animal models or the current in vitro tools, poorly representative of the real in vivo situation. This gap motivates the need for the development of alternative research tools, such as the fluidic devices, to study the mechanisms at play in human gut microenvironment and contribute to the success rate of expensive, risky and time-consuming pre-clinical and clinical trials. In this frame, our PROMETEO project aims to perform the technical and commercial feasibility of an integrated probiotic/gut epithelium/immune system millifluidic platform, based on a patented organ-on-a-chip technological device, providing the basis for a new generation of innovative solutions for probiotics/drug development. PROMETEO will be run by a consortium between Politecnico di Milano and AAT-Advanced Analytical Technologies, a forefront SME specialized in promoting innovation in the probiotic sector, thus combining a solid technological expertise and an in-depth knowledge of the market.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores